Effects of a phosphodiesterase type 5 inhibitor (SILDENAFIL) evaluated by 24-hour blood pressure monitoring and exercise capacity in heart transplanted patients. A double-blind, placebo-controlled, cross-over, randomized study. Preliminary results

Randomized Study ◽

Pressure Monitoring ◽

Double Blind ◽

Double Blind Placebo ◽

Preliminary Results ◽

Phosphodiesterase Type 5 Inhibitor ◽

Phosphodiesterase Type

Acute Effects of a Single Dose of Phosphodiesterase Type 5 Inhibitor (Sildenafil) on Systemic Arterial Blood Pressure During Exercise and 24-Hour Ambulatory Blood Pressure Monitoring in Heart Transplant Recipients

Transplantation Proceedings ◽

10.1016/j.transproceed.2007.04.029 ◽

2007 ◽

Vol 39 (10) ◽

pp. 3142-3149 ◽

Cited By ~ 10

Author(s):

G.V. Guimaraes ◽

V.M. d’Avila ◽

P. Pires ◽

F. Bacal ◽

N. Stolf ◽

...

Keyword(s):

Blood Pressure ◽

Single Dose ◽

Transplant Recipients ◽

Acute Effects ◽

Pressure Monitoring ◽

Arterial Blood ◽

Phosphodiesterase Type 5 Inhibitor ◽

Heart Transplant Recipients ◽

Phosphodiesterase Type

Sustained Antihypertensive Activity of Diltiazem SR: Double-Blind, Placebo-Controlled Study with 24-Hour Ambulatory Blood Pressure Monitoring

The Journal of Clinical Pharmacology ◽

10.1002/j.1552-4604.1992.tb03887.x ◽

1992 ◽

Vol 32 (9) ◽

pp. 808-815 ◽

Cited By ~ 12

Author(s):

Andrew Whelton ◽

Jack Eff ◽

David J. Magner

Keyword(s):

Blood Pressure ◽

Controlled Study ◽

Antihypertensive Activity ◽

Pressure Monitoring ◽

Double Blind ◽

Efficacy of losartan, valsartan, and telmisartan in patients with mild to moderate hypertension: A double-blind, placebo-controlled, crossover study using ambulatory blood pressure monitoring

Current Therapeutic Research ◽

10.1016/s0011-393x(02)80002-9 ◽

2002 ◽

Vol 63 (1) ◽

pp. 1-14 ◽

Cited By ~ 10

Author(s):

Roberto Fogari ◽

Amedeo Mugellini ◽

Annalisa Zoppi ◽

Giuseppe Derosa ◽

Andrea Rinaldi ◽

...

Keyword(s):

Blood Pressure ◽

Crossover Study ◽

Moderate Hypertension ◽

Pressure Monitoring ◽

Double Blind ◽

Additive Hypotensive Effect of a Dihydropyridine Calcium Antagonist to That Produced by a Thiazide Diuretic: A Double-Blind Placebo-Controlled Crossover Trial with Ambulatory Blood Pressure Monitoring

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199703000-00016 ◽

1997 ◽

Vol 29 (3) ◽

pp. 412-416 ◽

Cited By ~ 5

Author(s):

George S. Stergiou ◽

John S. Malakos ◽

Apostolos D. Achimastos ◽

Theodore D. Mountokalakis

Keyword(s):

Blood Pressure ◽

Calcium Antagonist ◽

Thiazide Diuretic ◽

Crossover Trial ◽

Hypotensive Effect ◽

Pressure Monitoring ◽

Double Blind ◽

An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension

American Journal of Hypertension ◽

10.1016/j.amjhyper.2005.03.259 ◽

2005 ◽

Vol 18 (5) ◽

pp. A93-A93 ◽

Cited By ~ 1

Author(s):

H PUNZI ◽

C PUNZI

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Pressure Monitoring ◽

Double Blind ◽

Verapamil 240 SR versus verapamil 120 SR in arterial hypertension. A randomized double-blind, placebo-controlled study with 24-hour ambulatory blood pressure monitoring

Cardiovascular Drugs and Therapy ◽

10.1007/bf02026498 ◽

1990 ◽

Vol 4 (6) ◽

pp. 1501-1507

Author(s):

Luigi Corea ◽

Maurizio Bentivoglio ◽

Silvano Berioli ◽

Carlo Bianchini ◽

Ketty Savino ◽

...

Keyword(s):

Blood Pressure ◽

Arterial Hypertension ◽

Controlled Study ◽

Pressure Monitoring ◽

Double Blind ◽

Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine in elderly patients with mild to moderate hypertension: a randomized, double-blind, cross-over study

European Journal of Clinical Pharmacology ◽

10.1007/s002280050344 ◽

1997 ◽

Vol 53 (2) ◽

pp. 95-100

Author(s):

D. Bonaduce ◽

V. Canonico ◽

M. Petretta ◽

L. Forgione ◽

A. Ianniciello ◽

...

Keyword(s):

Blood Pressure ◽

Elderly Patients ◽

Extended Release ◽

Moderate Hypertension ◽

Slow Release ◽

Pressure Monitoring ◽

Double Blind

Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: A multicenter double-blind placebo-controlled fixed-dose study

Diabetes Care ◽

10.2337/diacare.26.3.777 ◽

2003 ◽

Vol 26 (3) ◽

pp. 777-783 ◽

Cited By ~ 250

Author(s):

I. Goldstein ◽

J. M. Young ◽

J. Fischer ◽

K. Bangerter ◽

T. Segerson ◽

...

Keyword(s):

Erectile Dysfunction ◽

Fixed Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Phosphodiesterase Type 5 Inhibitor ◽

Dose Study ◽

Phosphodiesterase Type

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: The MAPAVEL study

Clinical Therapeutics ◽

10.1016/s0149-2918(02)85010-x ◽

2002 ◽

Vol 24 (1) ◽

pp. 126-138 ◽

Cited By ~ 24

Author(s):

Antonio Coca ◽

Carlos Calvo ◽

Juan García-Puig ◽

Blas Gil-Extremera ◽

Maria T Aguilera ◽

...

Keyword(s):

Blood Pressure ◽

Essential Hypertension ◽

Moderate Essential Hypertension ◽

Efficacy And Safety ◽

Pressure Monitoring ◽

Double Blind ◽

Blind Comparison

C017 Ambulatory blood pressure monitoring: Randomized study of hypertensive patients with left ventricular hypertrophy

American Journal of Hypertension ◽

10.1016/s0895-7061(97)90892-x ◽

1998 ◽

Vol 11 (4) ◽

pp. 52A

Author(s):

C MACHADO

Keyword(s):

Blood Pressure ◽

Left Ventricular Hypertrophy ◽

Ventricular Hypertrophy ◽

Randomized Study ◽

Left Ventricular ◽

Pressure Monitoring ◽

Hypertensive Patients